Question 1

Who are the latest insiders trading Sonnet BioTherapeutics Holdings, Inc. (SONN) stock?

Accepted Answer

The most recent insider trade for Sonnet BioTherapeutics Holdings, Inc. (SONN) was by Dexter Susan on July 11, 2025, who executed a purchase of 8,000 shares at $0.00 per share.

Question 2

How much SONN stock was sold by insiders this month?

Accepted Answer

There have been no insider sales recorded for Sonnet BioTherapeutics Holdings, Inc. (SONN) in the past 30 days. This could suggest insiders are holding their positions.

Question 3

Does Sonnet BioTherapeutics Holdings, Inc. show consistent insider selling or buying?

Accepted Answer

Over the last 12 months, insider activity at Sonnet BioTherapeutics Holdings, Inc. (SONN) shows a general trend of buying, with 0 sale transactions and 8 purchase transactions recorded.

Question 4

Are executives at Sonnet BioTherapeutics Holdings, Inc. actively trading their shares?

Accepted Answer

Yes, recent executive trades have been recorded. For example, Dexter Susan reported a purchase of 8,000 shares on 7/11/2025.

Sonnet BioTherapeutics Holdings, Inc.